Dan Galorath is founder and CEO of Galorath, a leader in cost estimation, actionable data and expertise for informed decision-making. Cost engineering has always been pivotal in balancing project ...
Under both the Donald Trump and Joe Biden administrations, the U.S. government has had a seemingly unquenchable thirst for national security regulations limiting investment, trade, and information ...
A building or other constructed facility provides shelter and service to its owners and occupants over a period of years. As this period extends to decades, portions of a building may be altered, ...
Air pollution contributes to the development of numerous adverse human health outcomes. The Environmental Protection Agency’s Environmental Benefits Mapping and Analysis Program–Community Edition ...
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial The economic evaluation, conducted from societal ...
The cost avoidance of heart failure–related hospitalizations and emergency department visits may outweigh the additional drug cost in Medicaid members adherent to sacubitril/valsartan. Objective: To ...
The inclusion of dynamic drug pricing in cost-effectiveness analysis is important for value assessments of new drugs. The drug price-related provisions of the Inflation Reduction Act make the case for ...
SAN FRANCISCO, CA—Earlier results from the COAPT trial have established that use of a MitraClip (Abbott) on top of guideline-directed medical therapy (GDMT) cuts mortality and heart failure ...
In 2022, our colleagues at the International Rescue Committee (IRC) were struggling to address one of the world’s most profound child health crises: hundreds of thousands of children in Chad suffering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results